Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
基本信息
- 批准号:7835556
- 负责人:
- 金额:$ 31.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-15 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAsiaAsiansBehaviorBehavior TherapyBehavioralChinaClinicCognitiveCollaborationsCost-Benefit AnalysisCosts and BenefitsCounselingCountryDataDevelopmentDoctor of PhilosophyDrug AddictionDrug CostsDrug abuseDrug usageDrug userEconomicsEnrollmentEnvironmentEpidemicEquipmentFellowshipHIVHIV InfectionsHeroinHeroin UsersHospitalsIndividualIndonesiaInformed ConsentInjecting drug userInjection of therapeutic agentInterventionLaboratoriesMalaysiaManualsMeasuresMethadoneNational Institute of Drug AbuseOpiate AddictionOpiatesParticipantPatientsPennsylvaniaPharmaceutical PreparationsPopulationPrevalenceProceduresRandomizedRecruitment ActivityRelative (related person)ResearchResearch PersonnelRiskRisk AssessmentRisk BehaviorsRisk ReductionStructureSystemTestingTimeUniversitiesUrinalysisWorkarmcostcost effectivedesigndrug efficacyevidence baseexperiencefollow-upgroup interventionmethadone clinic/centermethadone maintenanceprogramsprospectivepublic health relevancerandomized trialresponsescale upsex riskstandard caretooltreatment as usual
项目摘要
DESCRIPTION (provided by applicant): According to UNAIDS, Indonesia is experiencing one of the most rapidly expanding HIV/AIDS epidemics in Asia. The epidemic in Indonesia has been fueled by injection drug use among heroin users and the national response includes the scale-up of methadone maintenance treatment. Drug counseling is considered to be an integral part of methadone treatment, but few studies have been designed to assess its benefits and costs. In settings such as Jakarta, data regarding the costs and benefits of drug counseling have critical public heath relevance. We propose to conduct a prospective randomized trial to evaluate the efficacy of integrated drug and HIV counseling among injecting drug users. This study will be conducted at six methadone clinics in Jakarta, Indonesia where the HIV prevalence among injecting drug users ranges between 50- 86%, with collaborators from the Drug Dependence Hospital in Jakarta, the University of Pennsylvania and Yale University. The specific aims of this four year study are to evaluate the impact of Behavioral Drug and Risk Counseling (BDRC)-a low intensity, cognitive behavioral approach that integrates drug counseling and risk reduction intervention. Those assigned to the BDRC arm will be compared to those who receive treatment as usual which includes an initial risk reduction intervention and counseling as needed. We hypothesize that the structured, low intensity BDRC approach will be more cost effective and result in higher rates of retention in treatment, lower rates of drug use and lower rates of HIV risk. To test these hypotheses, the research team in Jakarta will recruit 300 injecting drug users as they enter treatment at the Drug Dependence Hospital and its five satellite programs. Following informed consent procedures, research staff will randomize participants to either the BDRC intervention or to treatment as usual. All subjects will be fuly assessed at baseline and months 3, 6, 9, and 12. The proposed work will be build on collaborations that have been established with the Indonesian Investigator Adhi Nurhidayat,MD during his NIDA INVEST Fellowship at University of Pennsylvania when he spent time with David Metzger, PhD and George Woody, MD. It will also extend findings from a WHO study on substitution therapy of opiates and HIV/AIDS that was completed by Riza Sarasvita, MS,MHS (former NIDA Humphrey Fellow at Johns Hopkins University) and her colleagues at The Drug Dependence Hospital Jakarta-Indonesia. PUBLIC HEALTH RELEVANCE: The AIDS epidemic in Indonesia has been fueled by injection drug use among heroin users and the National response includes the scale-up of methadone maintenance treatment. Drug counseling is considered to be an integral part of methadone treatment, but few studies have been designed to assess its benefits and costs. In settings such as Jakarta, data regarding the costs and benefits of integrated drug and risk counseling have critical public heath relevance.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID S METZGER其他文献
DAVID S METZGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID S METZGER', 18)}}的其他基金
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10197865 - 财政年份:2019
- 资助金额:
$ 31.44万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10436808 - 财政年份:2019
- 资助金额:
$ 31.44万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10654008 - 财政年份:2019
- 资助金额:
$ 31.44万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10004224 - 财政年份:2019
- 资助金额:
$ 31.44万 - 项目类别:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
快速启动丁丙诺啡/纳洛酮以优化费城 MAT 的利用
- 批准号:
9896726 - 财政年份:2018
- 资助金额:
$ 31.44万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
7687184 - 财政年份:2009
- 资助金额:
$ 31.44万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
8261981 - 财政年份:2009
- 资助金额:
$ 31.44万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
8085908 - 财政年份:2009
- 资助金额:
$ 31.44万 - 项目类别:
相似海外基金
Reducing HIV Stigma to Increase HIV Testing among Adolescents and Young Adults in Kazakhstan Using a Crowdsourcing Approach
使用众包方法减少艾滋病毒耻辱,增加哈萨克斯坦青少年和年轻人的艾滋病毒检测
- 批准号:
10302018 - 财政年份:2021
- 资助金额:
$ 31.44万 - 项目类别:
Reducing HIV Stigma to Increase HIV Testing among Adolescents and Young Adults in Kazakhstan Using a Crowdsourcing Approach
使用众包方法减少艾滋病毒耻辱,增加哈萨克斯坦青少年和年轻人的艾滋病毒检测
- 批准号:
10469437 - 财政年份:2021
- 资助金额:
$ 31.44万 - 项目类别:
Clinical Research Products Development Center (CRPMC)
临床研究产品开发中心(CRPMC)
- 批准号:
10197287 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别:
TB Research And Mentorship Program (TB RAMP)
结核病研究和指导计划 (TB RAMP)
- 批准号:
10066251 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别:
Clinical Research Products Management Center (CRPMC)
临床研究产品管理中心(CRPMC)
- 批准号:
10551073 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别: